Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-07-22Clinical Trial Update: Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis [NA]
The clinical trial evaluating probiotics for sputum inflammation and pulmonary infections in cystic fibrosis has been terminated; no results…
-
FDA approval · 2014-07-09FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Cayston (aztreonam) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis [NA]
A completed clinical trial evaluated non-invasive ventilation as a method for airway clearance in cystic fibrosis patients. Results were pos…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Aztreonam Lysine for Pseudomonas Infection Eradication Study [Phase 2]
Phase 2 trial update for aztreonam lysine aimed at eradicating Pseudomonas infection in cystic fibrosis; the completed study posted results …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis [NA]
A completed clinical trial evaluated the effect of hypertonic saline on mucus clearance in children aged 5-12 with cystic fibrosis; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis [NA]
A completed clinical trial investigating exhaled breath condensate collection to study ion regulation in cystic fibrosis and healthy control…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients [Phase 1]
This Phase 1 study evaluated safety, tolerability, and pharmacokinetics of tiotropium in cystic fibrosis patients. The update summarizes the…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® [Phase 3]
Phase 3 trial update comparing Tobrineb, Actitob, and Bramitob with TOBI in cystic fibrosis; results were posted in 2014.
-
FDA approval · 2014-06-13FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated. The action updates th…
-
CLINICAL_TRIALS research · 2014-05-29Clinical Trial Update: Cystic Fibrosis Related Diabetes [NA]
An update on a clinical trial related to Cystic Fibrosis-related diabetes; the study status is currently unknown.
-
FDA approval · 2014-05-19FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Cayston (aztreonam) by Gilead Sciences, Inc. This action updates the existing approval for Cayst…
-
CLINICAL_TRIALS research · 2014-05-06Clinical Trial Update: The Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis Clinic [NA]
This clinical trial update examines the effectiveness of a systemic mindfulness-based intervention program in a cystic fibrosis clinic; the …
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of sildenafil in cystic fibrosis lung disease has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways [Phase 3]
Phase 3 safety results for AZLI in children with cystic fibrosis and chronic Pseudomonas aeruginosa infection have been posted. The trial is…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis [Phase 4]
Phase 4 trial evaluating whether Pulmozyme delivered by the eRapid Nebulizer System has comparable efficacy and safety to standard delivery …
-
FDA approval · 2014-04-25FDA Approved: TOBI — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for TOBI (tobramycin inhalation solution) from Viatris Specialty LLC.
-
FDA approval · 2014-04-25FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for TOBI Podhaler (tobramycin inhalation powder) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects [Phase 1]
Phase 1 study evaluating bioequivalence and safety of Vantobra versus TOBI in healthy subjects; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) [Phase 3]
Phase 3 trial update reporting efficacy and safety results for Ultrase MT20 in improving the coefficient of fat absorption in children with …
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency [Phase 4]
Phase 4 clinical trial update on controlling steatorrhea in participants with cystic fibrosis and exocrine pancreatic insufficiency; results…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age [Phase 4]
This Phase 4 trial evaluated the mode of administration and safety of EUR-1008 (APT-1008) in infants aged 1 to 12 months with cystic fibrosi…
-
FDA approval · 2014-04-08FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated. The action updates the pr…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency [Phase 3]
Phase 3 study evaluating the safety and efficacy of EUR-1008 (APT-1008) pancreatic enzyme product in cystic fibrosis patients with exocrine …
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency [Phase 3]
A Phase 3 trial evaluating a pancreatic enzyme product in pediatric participants with cystic fibrosis and exocrine pancreatic insufficiency …
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy [Phase 2]
Phase 2 trial assessing whether a biofilm antimicrobial susceptibility assay can guide antibiotic therapy in cystic fibrosis patients.